LAM launches wound gel in Latin America:
This article was originally published in Clinica
Transdermal drug delivery systems specialist LAM Pharmaceutical today announced the launch of its IPM Wound Gel. Distributors and healthcare professionals from Argentina, Brazil, Costa Rica, Ecuador, El Salvador and Panama have expressed an interest in the gel, claims the Lewiston, New York-based company. It features LAM's Ionic Polymer Matrix (IPM) technology - "a combination of electrically charged and non-charged molecules with wound-healing properties". LAM has offices in Canada (Toronto) and China (Beijing).
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.